Shares of Merck KGaA (OTCMKTS:MKGAF – Get Free Report) saw strong trading volume on Friday . 5,656 shares traded hands during mid-day trading, an increase of 792% from the previous session’s volume of 634 shares.The stock last traded at $161.8470 and had previously closed at $161.15.
Merck KGaA Stock Performance
The stock has a market capitalization of $20.11 billion, a P/E ratio of 23.76 and a beta of 0.96. The firm has a 50-day moving average of $141.95 and a 200 day moving average of $142.53. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
